Project Grant R44HL156733
Award Date
7/1/21
Completion Date
6/30/23
Dollars Obligated
$4.2M
Federal Agency
National Heart Lung and Blood Institute
Awardee
Sonnest Inc. (S8LGPN7KL373)
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
This Project Grant from the National Heart, Lung and Blood Institute, part of the Department of Health and Human Services, was awarded under the Cardiovascular Diseases Research program (CFDA 93.837) to develop clinical software to support quantitative analysis and interpretation of myocardial contrast echocardiography (MCE) data. Narnar, LLC received $757,197 to create software modules that enhance MCE's ability to identify coronary microvascular dysfunction (MVD). The software will average...
This federal Project Grant award, worth $827,356.00, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The funding supports a prospective study to determine the imaging response to immune suppressant therapy in patients with active cardiac sarcoidosis. The study aims to establish quantitative thresholds for imaging parameters, such as FDG uptake on PET and advanced cardiac MRI measures, that are associated with...
This Project Grant award of $671,544, funded by the National Heart Lung and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837), aims to develop and validate a cardiac ultrasound radiomics-guided deep learning model for precision phenotyping and risk stratification of acute myocardial infarction (AMI) patients. The key products and services to be delivered under this award include: (1) benchmarking the radiomics-guided deep neural network model against conventional...
This Project Grant award from the National Heart Lung and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $343,203 to Cyion Technologies LLC to develop a novel in vitro electrophysiology system for high-throughput measurement of intracellular action potential (IAP) in human-derived cardiomyocytes. The system leverages a 3D nanoelectrode array (NEA) technology to enable scalable recordings of IAP signals from many individual cardiomyocytes. This...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $1,283,558 to the Massachusetts Institute of Technology (MIT) to develop multi-electroplasmonic nanoantenna arrays (MENAS) for wireless transmembrane-level recording of cardiomyocyte action potentials with sub-micrometer resolution. The goal is to create a breakthrough technology that will enable fundamental and pharmacological studies of cardiovascular systems at...
The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research (CFDA 93.837) program, awarded a $726,205 Project Grant to the University of Pittsburgh on April 22, 2025. The goal of this 4-year project is to develop and validate a new Super-Resolution Intravascular Ultrasound (SR-IVUS) technology to enable high-resolution 3D mapping of the coronary vasa vasorum network and accurately identify thin fibrous caps in vulnerable atherosclerotic plaques. The...
This $596,582 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports the development of Neuronoff Inc.'s Injectrode technology. The Injectrode is an injectable, flexible electrode designed for less invasive neural modulation therapies. The grant will fund the optimization and validation of the Injectrode for baroreceptor activation therapy to treat hypertension and heart failure. Neuronoff Inc. also...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $323,230 to Sirona Medical Technologies, Inc. to develop a customizable, multi-channel, dual energy source generator for their cardiac ablation catheters. The goal is to create hardware that can interface Sirona's ablation catheters with radiofrequency (RF) and pulsed field (PF) energy sources, and establish safe and effective signal...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $321,363 to Nucleusrx, Inc. to develop and test a virtual care platform and remote intervention tool targeting post-acute care heart failure (HF) patients. The goal is to create a solution that enables healthcare providers to implement a safe discharge transition plan from hospital to home, while allowing rapid optimization of...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $167,588 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to the Icahn School of Medicine at Mount Sinai (ISMMS). The grant, awarded on March 1, 2025, with a completion date of February 28, 2030, will support the career development of Dr. Son Duong, a clinician-scientist specializing in pediatric cardiology and advanced cardiovascular imaging. The primary objectives are to: 1) Develop and validate a...